Pfizer data boosts hopes children will soon be eligible for COVID-19 vaccine, and CDC expands booster program
October 22, 2021 at 10:54 AM EDT
There was good news for parents Friday when Pfizer said the vaccine it developed with German partner BioNTech proved 90.7% effective in preventing symptomatic COVID-19 in children aged 5 to 11 in a clinical trial, using a 10 mg dose instead of the 30 mg given to adults.
